<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSM828850"><item key="HMC1 SUBCLONE">devoid of CD2 surface receptor expression</item></item></item><item><item key="GSM828849"><item key="HMC1 SUBCLONE">expressing CD2 surface receptor</item></item></item></item><item key="id">2614</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">Systemic mastocytosis (SM) is an incurable neoplasm characterized by abnormal accumulation of neoplastic mast cells (MC) in vascularized...</item><item key="geo_gse_id">E-GEOD-33504</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">1</item><item key="sample_count">2</item><item key="tags"><item>cell</item><item>leukemia</item><item>line</item><item>mastocytosis</item><item>organ</item><item>p-selectin</item><item>peritoneum</item><item>scid</item><item>selectin</item><item>solid</item><item>surface</item><item>systemic mastocytosis</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">role-of-adhesion-receptors-in-mast-cell-disease-ev</item><item key="geo_id_plat">E-GEOD-33504_A-AFFY-44</item><item key="name">Role of adhesion receptors in mast cell disease-evolution</item><item key="created">Jul.12, 2014</item><item key="summary">Systemic mastocytosis (SM) is an incurable neoplasm characterized by abnormal accumulation of neoplastic mast cells (MC) in vascularized organs. In indolent SM, MC express several different adhesion-molecules including CD2 and CD58, and form focal tissue-aggregates, whereas in advanced SM, MC often lack CD2 and produce a more diffuse infiltration-pattern. To explore the functional role of CD2 in the pathology of SM, stable CD2+ and CD2&#8722; subclones of the human MC-leukemia cell line HMC-1 were generated and injected intraperitoneally into pfp/rag2 mice. CD2+ HMC-1 cells formed solid mastocytomas in the peritoneum and lungs, whereas CD2&#8722; cells produced diffuse infiltration. CD2+ and CD2&#8722; HMC-1 subclones all displayed the driver-mutant KIT D816V, exhibited the same growth-kinetics, and displayed identical adhesion-receptors including CD44 and selectin-ligands. To explore the mechanism of organ invasion, E- and P-selectin-deficient scid mice (scid-select) were employed. While massive HMC-1 infiltrates were detected in the lungs of control mice, infiltration was markedly reduced or absent in scid-select mice. The invasion-receptor CD44 was detectable in all MC infiltrates, with most abundant expression in the invasion-front. Together, our data show that selectins mediate organ-invasion of MC and CD2-CD58 interactions contribute to a more focal infiltration-pattern which is lost during progression to MC leukemia.  HMC1 cells were sorted by FACS for expression of CD2 surface expression. 2 subclones were obtained (CD2+ or CD2-) and compared by gene expression profiling using U133 plus 2.0 GeneChips</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-33504</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-33504/samples/</item></data></biogps>
